Grants to Medical, Scientific and Patient Organizations

Independent Medical Education (IME) Grants that may be awarded by Endo are in general for accredited continuing education (CE), certain qualified Fellowship/Resident programs, and certain independent educational programs for patients and/or caregivers when such programs are focused on topics that are planned and conducted in the interest of safeguarding public health.

Robust standards and policies assure that Endo IME Grants may only be provided in support of an educational initiative which is organized and conducted completely independent of influence from Endo and its representatives and/or agents. All Endo-supported IME activities must: 

  • be non-promotional in tone/nature
  • provide information that is fair and balanced
  • be accurate and not misleading
  • apply all applicable disclosures regarding Endo funding during the educational activity

IME Grant requests may be submitted 90 days prior to the start date of any associated educational activity via the online grant system. Accepted requests are evaluated based on objective criteria by the Endo Educational Grant Review Committee, and the Committee’s decisions are communicated in writing to the requesting organization via the online grant system. This uniform, centralized approach assures that each grant application within Endo’s therapeutic areas is consistently evaluated on the basis of its educational and scientific merit, potential contribution to the improvement of patient healthcare outcomes, compliance with all appropriate legal, regulatory, accreditation and industry code guidelines, and availability of budgetary resources.

Endo funded 17 IME Grants totaling $406,463.41 from January 1, 2019 through December 31, 2019.

About Endo


Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.


You are now leaving the website

Cancel Continue